» Articles » PMID: 33607163

Comparison of Memory, Affective Behavior, and Neuropathology in APP Knock-in Mice to 5xFAD and APP/PS1 Mice

Overview
Journal Behav Brain Res
Date 2021 Feb 19
PMID 33607163
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Transgenic mouse models of Aβ amyloidosis generated by knock-in of a humanized Aβ sequence can offer some advantages over the transgenic models that overexpress amyloid precursor protein (APP). However, systematic comparison of memory, behavioral, and neuropathological phenotypes between these models has not been well documented. In this study, we compared memory and affective behavior in APP mice, an APP knock-in model, to two widely used mouse models of Alzheimer's disease, 5xFAD and APP/PS1 mice, at 10 months of age. We found that, despite similar deficits in working memory, object recognition, and social recognition memory, APP and 5xFAD mice but not APP/PS1 mice show compelling anxiety- and depressive-like behavior, and exhibited a marked impairment of social interaction. We quantified corticolimbic Aβ plaques, which were lowest in APP, intermediate in APP/PS1, and highest in 5xFAD mice. Interestingly, analysis of plaque size revealed that plaques were largest in APP/PS1 mice, intermediate in 5xFAD mice, and smallest in APP mice. Finally, we observed a significantly higher percentage of the area occupied by plaques in both 5xFAD and APP/PS1 relative to APP mice. Overall, our findings suggest that the severity of Aβ neuropathology is not directly correlated with memory and affective behavior impairments between these three transgenic mouse models. Additionally, APP may represent a valid mouse model for studying AD comorbid with anxiety and depression.

Citing Articles

Advancing Alzheimer's Disease Modelling by Developing a Refined Biomimetic Brain Microenvironment for Facilitating High-Throughput Screening of Pharmacological Treatment Strategies.

Mohd Murshid N, Mohd Sahardi N, Makpol S Int J Mol Sci. 2025; 26(1.

PMID: 39796097 PMC: 11719782. DOI: 10.3390/ijms26010241.


Non-invasive volumetric ultrasound localization microscopy detects vascular changes in mice with Alzheimer's disease.

Jones R, DeRuiter R, Deshmukh M, Dayton P, Pinton G Theranostics. 2025; 15(3):1110-1121.

PMID: 39776806 PMC: 11700853. DOI: 10.7150/thno.99097.


The neural basis of neuropsychiatric symptoms in Alzheimer's disease.

Zhang N, Zhang S, Zhang L, Tao H, Zhang G Front Aging Neurosci. 2024; 16:1487875.

PMID: 39703925 PMC: 11655510. DOI: 10.3389/fnagi.2024.1487875.


Primate-specific 82-kDa choline acetyltransferase attenuates progression of Alzheimer's disease-like pathology in the APP knock-in mouse model.

AlQot H, Rylett R Sci Rep. 2024; 14(1):27614.

PMID: 39528509 PMC: 11555257. DOI: 10.1038/s41598-024-78751-2.


Blockade of brain alkaline phosphatase efficiently reduces amyloid-β plaque burden and associated cognitive impairment.

Soria-Tobar L, Roman-Valero L, Sebastian-Serrano A, Aivar P, Alvarez-Castelao B, Diaz-Hernandez M Alzheimers Res Ther. 2024; 16(1):233.

PMID: 39438925 PMC: 11494749. DOI: 10.1186/s13195-024-01600-x.


References
1.
Ambree O, Richter H, Sachser N, Lewejohann L, Dere E, De Souza Silva M . Levodopa ameliorates learning and memory deficits in a murine model of Alzheimer's disease. Neurobiol Aging. 2007; 30(8):1192-204. DOI: 10.1016/j.neurobiolaging.2007.11.010. View

2.
Whyte L, Hemsley K, Lau A, Hassiotis S, Saito T, Saido T . Reduction in open field activity in the absence of memory deficits in the App knock-in mouse model of Alzheimer's disease. Behav Brain Res. 2017; 336:177-181. DOI: 10.1016/j.bbr.2017.09.006. View

3.
Epis R, Gardoni F, Marcello E, Genazzani A, Canonico P, Di Luca M . Searching for new animal models of Alzheimer's disease. Eur J Pharmacol. 2009; 626(1):57-63. DOI: 10.1016/j.ejphar.2009.10.020. View

4.
Sakakibara Y, Sekiya M, Saito T, Saido T, Iijima K . Cognitive and emotional alterations in App knock-in mouse models of Aβ amyloidosis. BMC Neurosci. 2018; 19(1):46. PMC: 6064053. DOI: 10.1186/s12868-018-0446-8. View

5.
Hyman B, Phelps C, Beach T, Bigio E, Cairns N, Carrillo M . National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement. 2012; 8(1):1-13. PMC: 3266529. DOI: 10.1016/j.jalz.2011.10.007. View